Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Initial Inoperable”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06767527
What this trial is testing

AK112 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/ Metastatic Triple-negative Breast Cancer

Who this might be right for
Triple-Negative Breast Cancer (TNBC)
Akeso 416
Testing effectiveness (Phase 2)Active Not RecruitingNCT00492999
What this trial is testing

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center 64
Not applicableUnknownNCT06190847
What this trial is testing

Oral Microbiome is Associated With the Response to Chemoradiotherapy in Initial Inoperable Patients With Esophageal Squamous Cell Cancer

Who this might be right for
Esophageal Squamous Cell CarcinomaChemoradiotherapyInitial Inoperable
Anhui Provincial Hospital 97
Testing effectiveness (Phase 2)Study completedNCT00003953
What this trial is testing

Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Case Comprehensive Cancer Center 39
Post-approval studies (Phase 4)Looking for participantsNCT05035147
What this trial is testing

Albumin-bound Paclitaxel Combined With Gemcitabine First-line Inoperable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital 934
Testing effectiveness (Phase 2)Study completedNCT00166543
What this trial is testing

Three Doses of TAS-108 to Treat Recurrent or Recurrent Inoperable Breast Cancer

Who this might be right for
Breast Cancer
SRI International 146
Testing effectiveness (Phase 2)Study completedNCT03427814
What this trial is testing

Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer

Who this might be right for
Advanced or Inoperable Gastric Cancer
BeiGene 136
Testing effectiveness (Phase 2)Study completedNCT03469557
What this trial is testing

BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma, Gastric Carcinoma, Gastroesophageal Junction Carcinoma
BeiGene 30
Large-scale testing (Phase 3)Active Not RecruitingNCT06419621
What this trial is testing

PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBC

Who this might be right for
Triple Negative Breast Cancer(TNBC)
Biotheus Inc. 392
Testing effectiveness (Phase 2)UnknownNCT00024362
What this trial is testing

BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery

Who this might be right for
Pancreatic Cancer
Theradex
Testing effectiveness (Phase 2)UnknownNCT03512834
What this trial is testing

Paclitaxel-Avelumab for Angiosarcoma

Who this might be right for
Angiosarcoma Metastatic
Sung Yong Oh 32
Early research (Phase 1)Study completedNCT00909402
What this trial is testing

BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas

Who this might be right for
Stomach NeoplasmsEsophageal Neoplasms
Bristol-Myers Squibb 39
Large-scale testing (Phase 3)UnknownNCT05954442
What this trial is testing

Everolimus With Investigator's Choice of Chemotherapy in Advanced Triple-Negative Breast Cancer (TNBC) With Luminal Androgen Receptor (LAR) Subtype

Who this might be right for
Triple Negative Breast CancerMetastatic Breast CancerMutation
Fudan University 203
Testing effectiveness (Phase 2)Active Not RecruitingNCT04121455
What this trial is testing

Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients

Who this might be right for
Glioblastoma
TME Pharma AG 117
Testing effectiveness (Phase 2)Study completedNCT00635323
What this trial is testing

Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Pfizer 73
Testing effectiveness (Phase 2)Looking for participantsNCT06483347
What this trial is testing

Checkpoint Inhibitor Combinations Therapy as First Line for Inoperable Lung Cancer Via IT

Who this might be right for
Lung CancerInoperable Disease
Second Affiliated Hospital of Guangzhou Medical University 90
Not applicableStudy completedNCT03911219
What this trial is testing

Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus Chemotherapy

Who this might be right for
Stage IV Non-small Cell Lung CancerExtensive-stage Small Cell Lung CancerAdvanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC
iOMEDICO AG 154